ByTrending Posts
Regeneron to Present at 44th Annual J.P. Morgan…
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including…
Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical Association (JAMA) Neurology…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer…
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…
Is Samsung Biologics Set to Expand U.S. Operations…
Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug production facility from…
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription…
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…
Is McRae Tech Setting a New Standard for…
McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale, governed use of…
Is Sanofi Strengthening Its Adult Vaccine Strategy with…
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by announcing a $2.2…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma…
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan for Dupixent (dupilumab)…
Will Novartis’ $280M Gene Therapy Plant Transform Denton…
Denton, TX The Denton City Council has unanimously approved an economic development agreement with Novartis Gene Therapies, paving…
Trending Posts
Latest Stories
Regeneron to Present at 44th Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its…
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including Regained Strength and Extended Survival
Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca…
Is Samsung Biologics Set to Expand U.S. Operations with $280 Million GSK Acquisition?
Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug…
Gallery
